Prophylactic use of vacuum-assisted closure system for cannula sites: A case of extracorporeal biventricular assist devices for 295 days

We report wound management using a vacuum-assisted closure (VAC) system for the cannula sites of extracorporeal biventricular assist devices (BiVADs) for 295 days in a 23-year old Chinese female patient with fulminant giant cell myocarditis, who finally underwent heart transplantation. When the cann...

Full description

Saved in:
Bibliographic Details
Published in:International journal of artificial organs 2022-02, Vol.45 (2), p.227-230
Main Authors: Takami, Yoshiyuki, Tanida, Shin-ichi, Hoshino, Naoki, Sakurai, Yusuke, Amano, Kentaro, Akita, Kiyotoshi, Hayashi, Ryosuke, Maekawa, Atsuo, Izawa, Hideo, Takagi, Yasushi
Format: Article
Language:English
Subjects:
Adult
Airtightness
Cannula
Cannulae
Female
Heart diseases
Heart transplantation
Heart-Assist Devices - adverse effects
Humans
Infections
Myocarditis
Negative-Pressure Wound Therapy
Sepsis
Sepsis - etiology
Sepsis - prevention & control
Surgical Wound Infection
Transplantation
Vacuum
Wounds
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report wound management using a vacuum-assisted closure (VAC) system for the cannula sites of extracorporeal biventricular assist devices (BiVADs) for 295 days in a 23-year old Chinese female patient with fulminant giant cell myocarditis, who finally underwent heart transplantation. When the cannula sites appeared necrotic 3 months after BiVADs placement, she received negative pressure wound therapy prophylactically for four cannula sites, using a VAC system for 3 months, followed by no infections. Such prophylactic VAC therapy, using the skin barrier paste usually used for the ostomy pouching system to create a flatter surface and airtightness, may be useful to avoid cannula site infections, which is still a fatal complication causing sepsis, especially in patients with extracorporeal BiVADs.
ISSN:0391-3988
1724-6040
DOI:10.1177/0391398821991156